nicarbazin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5586 | 330-95-0 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Coccidiostat for poultry
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000981 | Antiprotozoal Agents |
| MeSH PA | D003049 | Coccidiostats |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Chickens | Prevention of outbreaks of cecal coccidiosis caused by Eimeria tenella | Indication |
| Chickens | Prevention of outbreaks of intestinal coccidiosis caused by E acervulina | Indication |
| Chickens | Prevention of outbreaks of intestinal coccidiosis caused by E maxima | Indication |
| Chickens | Prevention of outbreaks of intestinal coccidiosis caused by E necatrix | Indication |
| Chickens | Prevention of outbreaks of intestinal coccidiosis caused by E brunetti | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Nicarb 25% | Phibro Animal Health Corp. | 1 |
| Nicarbazin / Bacitracin Premix | Phibro Animal Health Corp. | 2 |
| Carbigran 25, Nicarbazin | Elanco US Inc. | 1 |
| Maxiban 72 | Elanco US Inc. | 2 |
| Nicarbazin (NICARB) plus Bambermycins (FLAVOMYCIN) | Huvepharma EOOD | 2 |
| BMD / Maxiban | Elanco US Inc. | 3 |
| Flavomycin / Maxiban | Elanco US Inc. | 3 |
| BMD / Maxiban | Zoetis Inc. | 3 |
| Nicarb / Baciferm | Phibro Animal Health Corp. | 2 |
| Nicarb 25% plus BMD | Zoetis Inc. | 2 |
| Inteprity and Maxiban | Elanco US Inc. | 3 |
| Pennitracin MD and Maxiban | Pharmgate Inc. | 3 |
| Nicarmix 25 | Planalquimica Industrial Ltda. | 1 |
| BMD / Nicarmix 25 | Planalquimica Industrial Ltda. | 2 |
| Albac 50 plus Nicarb | Zoetis Inc. | 2 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEMBL95855 | ChEMBL_ID |
| DB11434 | DRUGBANK_ID |
| D009528 | MESH_DESCRIPTOR_UI |
| C0028004 | UMLSCUI |
| 96165004 | SNOMEDCT_US |
| C18389 | KEGG_DRUG |
| 9507 | PUBCHEM_CID |
| 1311583 | RXNORM |
| 11P9NUA12U | UNII |
Pharmaceutical products:
None